Treatment Action Group has drafted a letter to Macleods, seeking their support in making pediatric TB medicines available in Europe. The letter has been drafted by 200+ pediatricians from 31 countries in Europe (the pTBnet). You can see the letter attached.
Macleods is global manufacturer that has made fixed dose combination and stand alone pediatric TB formulations available on the global market. TAG believes that a conversation to better understand Macleods’ perspectives regarding barriers to registration in Europe is a first step in coming up with a strategy for how to make urgently necessary pediatric formulations for TB medicines available in Europe.
If you are interested to sign this letter, please go to the Google form link: https://goo.gl/forms/3jx FLxaEmWV0K8Qn1 before COB ET, Monday, May 28th.
Please follow and like us: